Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Jonas Salk's inactivated polio vaccine (IPV) was licensed in 1955, and Albert Sabin's oral polio vaccine (OPV) followed in 1961 and 1962, so which one you received depends largely on where and when you were born. In the United States, most people vaccinated between the early 1960s and 1999 got the oral drops, while anyone vaccinated from 2000 onward received the injected IPV, and some children in the 1990s got a mixed schedule of both. Several factors affect your personal history, including your birth year, country, and how many doses you completed, so see below to understand which applies to you.
If you are trying to piece this together because of new symptoms such as muscle weakness, fatigue, joint pain, or trouble swallowing, guessing is rarely useful and waiting can delay answers. Take a free, instant, online symptom check to see what your symptoms may point to and get clear guidance on your next steps.
Last reviewed for medical accuracy: 10/01/2026
Polio, or poliomyelitis, was once a common and feared disease, especially among children. Thanks to vaccines, it’s now close to global eradication. Understanding when the polio vaccine was invented and which version you likely received can help you appreciate this public health triumph.
Before vaccines, polio epidemics struck every few years, causing paralysis or death in thousands. Scientists raced to find a way to stop the virus.
The answer involves two key milestones:
Inactivated Polio Vaccine (IPV) – Salk Vaccine
Oral Polio Vaccine (OPV) – Sabin Vaccine
These two vaccines remain the foundation of polio prevention worldwide.
Both vaccines train the immune system, but in slightly different ways:
IPV (Salk)
OPV (Sabin)
Your age and country of residence determine which vaccine you received.
If you were born in the United States after 2000, you almost certainly got IPV (Salk):
If you were born in the U.S. between 1963 and 2000, you likely received a combination of OPV and IPV:
If you grew up in other countries, vaccine type varied:
Each vaccine has strengths that complement the other:
Global polio eradication efforts often begin with OPV in regions at risk of outbreaks and then transition to IPV as cases decline.
Since the 1950s, polio cases have dropped by more than 99%:
This success is one of the greatest achievements in public health history.
Polio vaccines are among the safest vaccines available. Common mild side effects may include:
Severe reactions are extremely rare. The benefits of polio vaccination—preventing paralysis and death—far outweigh these minor risks.
To finish the job of polio eradication, health organizations focus on:
Keeping polio at zero worldwide requires continued vigilance until the virus is gone for good.
Even though polio is rare, other conditions can cause muscle weakness or fever. If you or your child experiences worrying symptoms:
Vaccination remains the best protection against polio and many other serious diseases. Staying up to date with recommended vaccines is a simple way to safeguard your health and that of your community.
(References)
* Meldrum M. "A calculated risk": the Salk polio vaccine field trials of 1954. BMJ. 1998 Oct 31;317(7167):1233-6. doi: 10.1136/bmj.317.7167.1233. PMID: 9794869; PMCID: PMC1114166.
* REPORT on development of polio vaccine. Phys Ther Rev (1948). 1953 Nov;33(11):603-4. PMID: 13120362.
* NATHANSON N, LANGMUIR AD. THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND. Am J Hyg. 1963 Jul;78:16-28. doi: 10.1093/oxfordjournals.aje.a120327. PMID: 14043543.
* NATHANSON N, LANGMUIR AD. THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. II. RELATIONSHIP OF POLIOMYELITIS TO CUTTER VACCINE. Am J Hyg. 1963 Jul;78:29-60. doi: 10.1093/oxfordjournals.aje.a120328. PMID: 14043545.
* FERGUSON JK. THE STORY OF POLIOMYELITIS VACCINES. Can J Public Health. 1964 May;55:183-90. PMID: 14161448.
* MAYER L. ORTHOPAEDIC ADVANCES OF THE LAST 50 YEARS AND THE PROBLEMS WE OF THE OLDER GENERATION HAND OVER TO THE YOUNGER FOR SOLUTION. Bull Hosp Joint Dis. 1964 Apr;25:11-20. PMID: 14216088.
* Báguena Cervellera MJ. [Epidemiological and virological studies into the poliomyelitis in Valencia (1959-1969)]. Asclepio. 2009;61(1):39-54. doi: 10.3989/asclepio.2009.v61.i1.271. PMID: 19750610.
* Martínez-Pérez J. [Consolidating the medical model of disability: on poliomyelitis and constitution of orthopedic surgery and orthopaedics as a speciality in Spain (1930-1950)]. Asclepio. 2009;61(1):117-42. doi: 10.3989/asclepio.2009.v61.i1.274. PMID: 19753686.
* Ali D, Banda R, Mohammed A, Adagadzu J, Murele B, Seruyange R, Makam J, Mkanda P, Okpessen B, Tegegne SG, Folorunsho AS, Erbeto TB, Yehualashet YG, Vaz RG. Strengthening Routine Immunization in Areas of Northern Nigeria at High Risk for Polio Transmission During 2012-2014. J Infect Dis. 2016 May 1;213 Suppl 3(Suppl 3):S147-50. doi: 10.1093/infdis/jiv580. Epub 2016 Feb 24. PMID: 26917576; PMCID: PMC4818556.
* Velázquez-Arellano A. [A forgotten chapter of Mexican technology and science: Luis Gutiérrez Villegas and poliomyelitis in Mexico]. Gac Med Mex. 2017;153(5):633-640. doi: 10.24875/GMM.17003060. PMID: 29099101.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.